Multi-omics in Crohn's disease: New insights from inside

Area of Science:

• Gastroenterology and Immunology
• Genomics, Epigenomics, Microbiomics, Metabolomics, and Proteomics

Background:

• Crohn's disease (CD), a type of inflammatory bowel disease (IBD), presents complex symptoms and lacks a definitive cure despite rising global incidence.
• Current understanding of CD pathogenesis is limited by the inability of single omics technologies to holistically address disease heterogeneity.

Purpose of the Study:

• To review and synthesize the distinct omics features and applications relevant to Crohn's disease research.
• To discuss the current advancements and limitations of multi-omics approaches in exploring CD.
• To highlight the potential of integrated omics for developing targeted, personalized therapeutics for CD.

Main Methods:

• Review of high-throughput sequencing technologies and integrated omics analyses, including genomics, epigenomics, microbiome, metabolomics, and proteomics.
• Analysis of how different omics data types contribute to understanding CD pathogenesis, biomarkers, and host-microbe interactions.
• Emphasis on the integration of multiple omics datasets for a comprehensive view of CD.

Main Results:

• Host genomics and epigenomics reveal hereditary factors in CD susceptibility.
• Microbiome and metabolomics studies elucidate host-microbe interactions in CD patients.
• Proteomics shows promise for identifying CD biomarkers.

Conclusions:

• Single omics approaches are insufficient for fully connecting CD mechanisms with pathological heterogeneity.
• Multi-omics analysis, by integrating diverse data, provides a powerful tool for in-depth CD exploration.
• This integrated approach offers new hope for advancing targeted and individualized therapeutic strategies for Crohn's disease.